Littlejohn & Co’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Littlejohn & Co’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,332	Closed	-$1.24K	–	66
2022 Q4	$1.24K	Hold	8,332	–	–	﹤0.01%	42
2022 Q3	$1K	Hold	8,332	–	–	﹤0.01%	69
2022 Q2	$1K	Hold	8,332	–	–	﹤0.01%	142
2022 Q1	$7K	Hold	8,332	–	–	﹤0.01%	124
2021 Q4	$5K	Hold	8,332	–	–	﹤0.01%	160
2021 Q3	$8K	Hold	8,332	–	–	﹤0.01%	173
2021 Q2	$12K	Buy	+8,332	New	+$7.27K	﹤0.01%	177

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Littlejohn & Co's PEARW Position: Q2 2023 in Review

Littlejohn & Co sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 8,332 shares — an estimated $158 sold.

Littlejohn & Co first reported a position in PEARW in Q1 2023 and held it in 1 quarter. The position peaked at $158 in Q1 2023. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Littlejohn & Co reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Littlejohn & Co sold 8,332 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $158.
Littlejohn & Co first reported a position in Pear Therapeutics, Inc. Warrant in Q1 2023 and held it in 1 quarter.
Littlejohn & Co's Pear Therapeutics, Inc. Warrant position peaked at $158 in Q1 2023.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Littlejohn & Co's 13F filing for Q2 2023, filed 9 Aug 2023.